UA98460C2 - Применение ингибиторов ионных task-1 i task-3 каналов - Google Patents

Применение ингибиторов ионных task-1 i task-3 каналов

Info

Publication number
UA98460C2
UA98460C2 UAA200813665A UAA200813665A UA98460C2 UA 98460 C2 UA98460 C2 UA 98460C2 UA A200813665 A UAA200813665 A UA A200813665A UA A200813665 A UAA200813665 A UA A200813665A UA 98460 C2 UA98460 C2 UA 98460C2
Authority
UA
Ukraine
Prior art keywords
disorders
cancer
disease
respiratory disorders
task
Prior art date
Application number
UAA200813665A
Other languages
English (en)
Ukrainian (uk)
Inventor
Йоахим Брендель
Хайнц Гегеляйн
Клаус ВИРТ
Вальтер КАММ
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Priority claimed from PCT/EP2007/003293 external-priority patent/WO2007124849A2/en
Publication of UA98460C2 publication Critical patent/UA98460C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Изобретение касается использования ингибиторов Kvl.5 для получения лекарственного средства для лечения или профилактики респираторных расстройств, респираторных расстройств во сне, приступов центрального и обструктивного апноэ во сне, синдрома нарушения проходимости верхних дыхательных путей, дыхания Чейн-Стокса, храпения, нарушения центральной регуляции дыхания, внезапной детской смерти, послеоперационной гипоксии и апноэ, мышечных респираторных расстройств, респираторных расстройств после продолжительной вентиляции легких, респираторных расстройств во время адаптации в высоких горах, острых и хронических легочных расстройств с гипоксией и гиперкапнией; нейродегенеративных расстройств, деменции, болезни Альцгеймера, болезни Паркинсона и болезни Гентингтона; раковых за
UAA200813665A 2006-04-27 2007-04-13 Применение ингибиторов ионных task-1 i task-3 каналов UA98460C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006019589A DE102006019589A1 (de) 2006-04-27 2006-04-27 Inhibitoren des TASK-1 und Task-3 Ionenkanals
PCT/EP2007/003293 WO2007124849A2 (en) 2006-04-27 2007-04-13 Inhibitors of the task-1 and task-3 ion channel

Publications (1)

Publication Number Publication Date
UA98460C2 true UA98460C2 (ru) 2012-05-25

Family

ID=38542297

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200813665A UA98460C2 (ru) 2006-04-27 2007-04-13 Применение ингибиторов ионных task-1 i task-3 каналов

Country Status (4)

Country Link
DE (1) DE102006019589A1 (ru)
HN (1) HN2008001585A (ru)
UA (1) UA98460C2 (ru)
ZA (1) ZA200808171B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016365676A1 (en) * 2015-12-10 2018-06-07 Bayer Pharma Aktiengesellschaft 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of TASK-1 and TASK-2 channels, for the treatment of sleep-related breathing disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
CA2311483A1 (en) * 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
US6620849B2 (en) * 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
WO2005030727A1 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
US7906521B2 (en) * 2003-09-23 2011-03-15 Merck Sharp & Dohme Corp. Quinazoline potassium channel inhibitors
CA2539729C (en) * 2003-09-23 2010-09-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
CN1856475A (zh) * 2003-09-23 2006-11-01 默克公司 异喹啉钾通道抑制剂
WO2005034837A2 (en) * 2003-10-08 2005-04-21 Cardiome Pharma Corporation 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS
JP4719744B2 (ja) * 2004-07-29 2011-07-06 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャンネル阻害剤
AU2005311251A1 (en) * 2004-12-01 2006-06-08 Devgen Nv 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the Kv family
AU2005318465A1 (en) * 2004-12-21 2006-06-29 Devgen N.V. Compounds with Kv4 ion channel activity
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
ZA200808171B (en) 2009-10-28
DE102006019589A1 (de) 2007-10-31
HN2008001585A (es) 2011-04-25

Similar Documents

Publication Publication Date Title
TNSN08431A1 (en) Inhibitors of the task-1 and task -3 ion channel
GEP20227366B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
PH12018501235A1 (en) 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
TN2020000021A1 (en) Substituted diazahetero-bicyclic compounds and their use
PH12019501408A1 (en) Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
WO2010023590A3 (en) Respiratory patient interfaces
PH12019501458A1 (en) Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
MX2021003428A (es) Antagonistas del receptor adrenérgico a2 subtipo c (alfa-2c) para el tratamiento de la apnea del sueño.
PH12021551186A1 (en) Process for producing pharmaceutical dosage forms comprising inhibitors of task-1 and task-3 channels and use thereof for therapy of respiratory disorders
WO2015061790A3 (en) Genetically-associated chronic obstructive pulmonary disease treatment
UA98460C2 (ru) Применение ингибиторов ионных task-1 i task-3 каналов
MX2009010805A (es) Metodos y composiciones que comprenden desvenlafaxina o duloxetina para el tratamiento de trastornos de la respiracion relacionados con el sueño.
JP2010523662A5 (ru)
TH91927A (th) สารยับยั้ง task-1 และ task-3 ไอออนแชนเนล
EP2763687A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC SYNDROME, OBSTRUCTIVE RESPIRATORY DISORDERS, CANCER AND RELATED DISEASES
Mohankumar Do all nocturnal asthmatics need a polysomnographic evaluation?
Koo et al. Respiratory analysis in patients with obstructive sleep apnea syndrome (OSAS): mixed vs. predominant obstructive vs. pure obstructive
AU2006904770A0 (en) Automatic Positive Airway Pressure Therapy through the nose or mouth for treatment of Sleep Apnea and other respiratory disorders
Gakwaya et al. Impact Of Mandibular Advancement Device Associated With CPAP Interface On Upper Airway Mechanical Properties Assessed By Phrenic Nerve Stimulation In Patients With Obstructive Sleep Apnea
Bettinzoli et al. Oronasal Mask Require Higher Levels Of Positive Airway Pressure To Treat Obstructive Sleep Apnea Compared To Nasal Mask
UA35600U (ru) Способ лечения хронического обструктивного заболевания легких
UA35671U (ru) Способ лечения больных хроническим обструктивным заболеванием легких на фоне гипертонической болезни
CN302135101S (zh) 睡眠时的呼吸确保用管